J Biol Chem, Vol. 274, Issue 37, 26225-26232, September 10, 1999
Dissecting the Role of a Conserved Motif (the Second Region of
Homology) in the AAA Family of ATPases
SITE-DIRECTED MUTAGENESIS OF THE ATP-DEPENDENT PROTEASE
FtsH*
Kiyonobu
Karata
,
Takabumi
Inagawa
,
Anthony J.
Wilkinson§,
Takashi
Tatsuta
, and
Teru
Ogura
¶
From the
Department of Molecular Cell Biology,
Institute of Molecular Embryology and Genetics, Kumamoto University
School of Medicine, Kumamoto 862-0976, Japan and the
§ Department of Chemistry, University of York,
York YO1 5DD, United Kingdom
 |
ABSTRACT |
Escherichia coli FtsH is an
ATP-dependent protease that belongs to the AAA protein
family. The second region of homology (SRH) is a highly conserved motif
among AAA family members and distinguishes these proteins in part from
the wider family of Walker-type ATPases. Despite its conservation
across the AAA family of proteins, very little is known concerning the
function of the SRH. To address this question, we introduced point
mutations systematically into the SRH of FtsH and studied the
activities of the mutant proteins. Highly conserved amino acid residues
within the SRH were found to be critical for the function of FtsH, with
mutations at these positions leading to decreased or abolished ATPase
activity. The effects of the mutations on the protease activity of FtsH
correlated strikingly with their effects on the ATPase activity. The
ATPase-deficient SRH mutants underwent an ATP-induced conformational
change similar to wild type FtsH, suggesting an important role for the
SRH in ATP hydrolysis but not ATP binding. Analysis of the data in the light of the crystal structure of the hexamerization domain of N-ethylmaleimide-sensitive fusion protein suggests a
plausible mechanism of ATP hydrolysis by the AAA ATPases, which invokes an intermolecular catalytic role for the SRH.
 |
INTRODUCTION |
The AAA protein family (for ATPases
associated with diverse cellular activities) is
a distinct subfamily of the Walker-type ATPases that has been defined
on the basis of amino acid sequence homology (for reviews see Refs.
1-3). Walker-type ATPases have two consensus motifs, Walker A and B. In addition to these consensus motifs, AAA proteins have another highly
conserved amino acid sequence within their ATPase domain that has been
termed the second region of homology
(SRH)1 (4). A 200-250-amino
acid residue sequence that encompasses the Walker A and B motifs and
the SRH is named the AAA module, and proteins that contain one or two
copies of this module are classified into the AAA protein family. Thus,
the SRH is the defining feature that distinguishes the AAA family from
other Walker-type ATPases.
FtsH of Escherichia coli is the first identified prokaryotic
member of the AAA family (5, 6). FtsH is a membrane-bound ATP-dependent protease with two N-terminal transmembrane
segments (Fig. 1) (7, 8). It possesses one copy of the AAA module and
at its C terminus possesses a Zn2+-binding motif, which is
thought to be the catalytic center for proteolysis. Several substrates
of FtsH have been identified, including cytoplasmic proteins, such as
the heat shock transcription factor
32 (8, 9), LpxC
(10), SsrA-tagged proteins (11),
CII (12),
CIII (13), and
Xis (14), as well as integral membrane proteins such as SecY (15, 16),
subunit a of the proton ATPase FO sector (17),
and YccA (18). Although FtsH is essential for cell growth (5, 19),
cells lacking ftsH can grow if the sfhC mutation
coexists (10, 20). Interestingly, several findings have also raised the
possibility that FtsH has a chaperone-like activity. Some
ftsH mutations cause abnormal protein translocation and
defects in protein export. In particular, it has been shown that the
PhoA moiety of SecY-PhoA fusions, in which PhoA is attached to the
C-terminal cytoplasmic region of SecY, is abnormally translocated (Std
phenotype) in ftsH mutant strains (19, 21). These phenotypes are differentially suppressed by overproduction of other chaperones (22). The data also indicated that FtsH binds to denatured but not
intact PhoA polypeptide and that this binding does not result in
proteolysis of PhoA (23).
The AAA family has been growing rapidly for the past several years with
more than 200 family members identified to date. Members of this family
are spread among various species in all kingdoms, archaea, bacteria,
and eukaryotes and participate in various cellular activities. The AAA
family can be divided into at least six subfamilies: metalloproteases
including FtsH, subunits of the 26 S proteasome, proteins involved in
vesicle-mediated secretion, homotypic fusion, peroxisome biogenesis,
and meiosis/mitochondrial functions. No clue to the common function of
AAA proteins, besides ATP binding and/or hydrolysis, has yet emerged.
There appears to be a confusing contrast between the extreme sequence
conservation within the module and the diversity of function of the AAA
proteins. There must be a very important reason for this high
conservation of sequence both among proteins with a common function in
evolutionarily distant species, as well as among AAA proteins with a
variety of functions within the cell of a given species. Elucidation of
the basic function of the module represents an exciting challenge, and
it must provide a clue to understanding the common function of the
AAA proteins.
Because the SRH is a part of the ATPase domain, it is assumed to have
some relation to the ATPase activity. However, there have as yet been
no reports of an experimental investigation into the function of the
SRH. To elucidate SRH function, we introduced a series of mutations
into the SRH sequence of E. coli FtsH and studied their
consequences both in vivo and in vitro. The
results indicate that the SRH is important for the ATPase activity.
 |
EXPERIMENTAL PROCEDURES |
Strains and Media--
AR3289 (sfhC21
zad220::Tn10) (10, 20), AR423 (met gal
supE hsdR sfiC
(srl-recA)306::Tn10
ftsH3::kan [pAR171,
ftsH+ repts
camR]) (19), AR754 (thr-1 leu-6 thi-1 supE44
lacY1 tonA21 zha-6::Tn10 ftsH1) (24), and
BL21(DE3) (F
ompT hsdS gal dcm [DE3]) (25)
have been described. AR5074 (BL21[DE3] sfhC21
zad220::Tn10) was constructed by P1
transduction of sfhC21 zad220::Tn10
from AR3289 into BL21(DE3). AR5088 (AR5074
ftsH3::kan) was constructed by P1
transduction of
ftsH3::kan from
AR423 into AR5074. XL1-Blue (recA1 endA1 gyrA96 thi-1 hsdR17
supE44 relA1 lac [F'::Tn10,
proA+B+
lacIqZ
M15]) was used as a
host strain to construct plasmids in this study.
L medium (10 g of tryptone, 5 g of yeast extract, 5 g
NaCl/liter, pH 7.4) was used. Ampicillin (100 µg/ml) was added for
growing strains carrying plasmids.
Plasmids--
pUC118 carries the gene for ampicillin resistance
(ampR). pET29b is a plasmid vector of the pET
system carrying the T7 promoter (Novagen). pKY297 carries a truncated
ftsH gene that lacks the sequence encoding the two
transmembrane segments and the Walker motifs (21). pSTD401 carries the
wild type ftsH gene with its own Shine-Dalgarno sequence
under the control of the lac promoter (19). pSTD41 carries
the K201N mutant ftsH gene (21). pQM21 carries the H421Y
mutant ftsH gene (26). pIFH100 is the plasmid vector used in
this study and was constructed as follows. The NdeI-BamHI fragment of pET29b was deleted to
eliminate the S·Tag sequence, and the NsiI short fragment
of the resulting plasmid was replaced with the BspHI
ampR-containing fragment of pUC118 by blunt end
ligation after treatment with Klenow fragment. pIFH108 is the wild type
FtsH expressing plasmid constructed by inserting the
EcoRI-HindIII ftsH fragment of pSTD401
into pIFH100. We checked the whole sequence of the cloned
ftsH gene on pIFH108 and found a silent mutation of
Ala163 (GCA to GCG) in the ftsH coding region.
Construction of Mutant ftsH Plasmids--
All mutant
ftsH plasmids were constructed by replacing a segment of
ftsH on pIFH108 with a mutated fragment. The numbering of
amino acid residues of FtsH was according to Wang et al.
(27). The mutants are as follows: 1) K201N (AAA to AAC): the
KpnI-PstI segment of pIFH108 was replaced with
the corresponding segment of pSTD41. 2) V296A (GTT to GCA), T300A (ACT
to GCT), N301A (AAC to GCA), P303A (CCG to GCG), D304A (GAC to GCC),
D307A (GAC to GCG), D307N (GAC to AAC), D307E (GAC to GAG), L310A (CTG
to GCG), R312A (CGT to GCT), R312L (CGT to CTT), R312K (CGT to AAA),
G314A (GGC to GCA), R315A (CGT to GCA), R315L (CGT to CTT), and R315K (CGT to AAA): mutagenized ftsH fragments were produced by
sequential polymerase chain reaction steps using synthetic primers
(28). The KpnI-NcoI segment of pIFH108 was
replaced with each mutated fragment. 3) E418Q (GAA to CAG): the mutated
fragment was produced by sequential polymerase chain reaction steps.
The fragment digested with MluI and Bsu36I was
cloned into pKY297. The KpnI-PstI fragment was
then subcloned into pIFH108. 4) H421Y (CAT to TAT): the
KpnI-PstI segment of pQM21 was subcloned into
pIFH108. We checked the whole sequence of ftsH to confirm
that no other mutations had been introduced adventitiously.
Purification of FtsH--
AR5088 cells carrying pIFH108 were
grown in 2 liters of L medium containing ampicillin (100 µg/ml) at
37 °C to a cell density corresponding to 50 Klett units. At this
point, expression of FtsH was induced by the addition of IPTG (1 mM) followed by growth for a further 3 h.
Crude membranes were prepared and homogenized as described (8) and
solubilized by 0.2% sodium lauryl sarcosinate (Sarkosyl). The
solubilized preparation was dialyzed against buffer A (20 mM monoethanolamine HCl, pH 9.0, 1 mM EDTA, 1 mM dithiothreitol, 10% glycerol, 0.5% Nonidet P-40).
MonoQ fractionation was carried out with buffer A and buffer B (buffer
A containing 1 M NaCl). Pooled MonoQ fractions were applied
to a Superose 6 size fractionation column in buffer A. Pooled Superose
6 fractions were applied to a MonoP fractionation column with buffers A
and B. The peak fraction of FtsH was dialyzed against dialysis buffer
(20 mM monoethanolamine HCl, pH 9.0, 5 mM
magnesium acetate, 10% glycerol, 0.5% Nonidet P-40) and used for
in vitro assays.
Assay for in Vitro Degradation of
32--
The
proteolytic activity of purified wild type and mutant FtsH proteins was
assayed as described (8).
Assay for NTPase Activity--
NTPase activities were assayed
using ATP, GTP, CTP, or UTP as described (16).
ATP-induced Conformational Change of FtsH--
Conformational
changes of FtsH induced by ATP were analyzed according to the
procedures described by Akiyama et al. (23). The reaction
was started by the addition of 2.5 µg/ml of trypsin. Samples were
removed at intervals, and analyzed by 10% SDS-polyacrylamide gel
electrophoresis (PAGE) followed by immunoblotting using the anti-FtsH
serum and detected by ECL (Amersham Pharmacia Biotech).
Western Blotting--
1 ml of culture (Klett unit = 50) was
harvested by centrifugation. Pelleted cells were suspended in 100 µl
of the SDS loading buffer. 20 µl of the samples were analyzed by
SDS-PAGE followed by immunoblotting using anti-FtsH or
anti-
32 serum (29) and detected by ECL.
 |
RESULTS |
Development of a System That Facilitates Both in Vivo Functional
Analysis and Purification of Mutant FtsH Proteins--
To examine the
activity of mutant FtsH proteins in vivo and to purify them
without contamination from wild type FtsH, it is necessary to use a
strain lacking the ftsH gene as a host. Recently, we have
identified a suppressor mutation, sfhC, that allows cells lacking ftsH to survive (10, 20). To take advantage of the efficient pET expression vectors that utilize the T7 promoter, we
constructed a derivative of BL21(DE3) carrying
ftsH and
sfhC, AR5088, and cloned the ftsH gene on a
derivative of pET29b, pIFH108.
In this system, intact FtsH protein is expressed from pIFH108, and its
expression is inducible by IPTG. We found that this system has an
additional merit. In the absence of IPTG, expression of FtsH from
pIFH108 in AR5088 was leaky such that levels of FtsH comparable with
that derived from the wild type chromosomal ftsH gene are
produced (see Fig. 2, A and B, lanes
1, 2, and 5). This property allows the
in vivo activity of mutant FtsH proteins in AR5088 to be assayed.
In principle, FtsH cannot be induced from pIFH108 in host strains other
than
DE3 lysogens owing to the absence of T7 RNA polymerase. Indeed
as expected, we observed negligible expression of FtsH from pIFH108 in
such strains in the absence of IPTG. However, somewhat surprisingly, in
the presence of IPTG, the level of expression of FtsH from pIFH108 was
comparable with that from the chromosomal ftsH gene (data
not shown). Although the mechanism underlying this observation is not
understood, this property was exploited in the complementation
experiments with the temperature-sensitive mutant strain (see Fig.
3).
Construction of SRH Mutant Plasmids by Site-directed Mutagenesis
and Their Protease Activity in Vivo--
Several amino acid residues
such as Thr300, Asn301, Asp307,
Ala309, Arg312, and Arg315 in the
SRH of FtsH are very highly conserved among the AAA family proteins
(Fig. 1B), whereas others are
less well conserved. Changing each residue to Ala, in what is termed
"alanine scanning," is a useful strategy for identifying
functionally important residues in proteins (30). To determine whether
or not the SRH is important for FtsH function and, if so, which amino
acid residues in the SRH are important, we introduced Ala substitutions
into some conserved and less conserved residues in the SRH.

View larger version (42K):
[in this window]
[in a new window]
|
Fig. 1.
Structure of FtsH and the amino acid
conservation of the SRH. A, schematic representation of
FtsH. TM1 and TM2 are transmembrane regions. The SRH is defined
according to Lenzen et al. (31). The numbers
above the sequence indicate the amino acid residues in FtsH and
are based on the revised sequence reported by Wang et al.
(27). The letters under the sequence indicate the amino acid
substitutions constructed in this study. B, amino acid
conservation in the SRH. Sequences of the SRH of 54 representative AAA
proteins, which are listed in the data base BLOCKS (BL00674D), were
analyzed. Conserved amino acids (>50%) are indicated by filled
bars. Bars shorter than 100% are due to the lack of
amino acid residues at the corresponding positions in some AAA modules.
The numbering is again that of FtsH. The predicted secondary structure
elements, based on the crystal structure of D2 of NSF, are
underlined (31, 32, 43).
|
|
Plasmids expressing wild type or mutant FtsH were introduced into
AR5088, and the levels of
32, which is one of the known
specific substrates of the FtsH protease (8, 9), were analyzed by
Western blotting (Fig. 2A). In untransformed AR5088 (
ftsH) or AR5088 harboring the
vector pIFH100,
32 accumulated (Fig. 2A,
lanes 3 and 4). When wild type FtsH was expressed
from pIFH108, the accumulation of
32 was not observed
(Fig. 2A, lane 5). In the case of mutants of less
conserved residues such as V296A, P303A, D304A, and G314A, the
accumulation of
32 was not observed (Fig. 2A,
lanes 6, 9, 10, and 14),
indicating that these mutants have almost the same activity as wild
type FtsH and that these less conserved residues are not important for
the in vivo protease activity of FtsH. On the other hand, with the mutants of the highly conserved residues N301A, D307A, R312A,
and R315A,
32 accumulated to the same levels as those in
AR5088 harboring the vector (Fig. 2A, lanes 8,
11, 13, and 15), indicating that these highly conserved residues are essential for the in vivo
protease activity of FtsH. In cells expressing the T300A or L310A
mutants, the accumulation of
32 was partially suppressed
(Fig. 2A, lanes 7 and 12), suggesting that these mutants have a low protease activity. This implies that
Thr300 and Leu310 are less important. Overall,
these results indicate that the SRH is important for FtsH function and
that there is good correlation between the functional importance and
the extent of conservation of the amino acid residues in the SRH.

View larger version (79K):
[in this window]
[in a new window]
|
Fig. 2.
In vivo protease activity of wild
type and mutant FtsH proteins. A, Western blotting with
anti-FtsH and anti- 32 antisera. vector and
wild-type represent pIFH100 and pIFH108, respectively.
Lanes 6-15 represent alanine scanning mutants of pIFH108.
Strains AR5074 (sfhC) and AR5088 (sfhC
ftsH) are derivatives of BL21(DE3). AR5088 was used as
the host for all of the plasmids (lanes 4-15). Cells were
cultured in the absence of IPTG at 37 °C. B, same as in
A except that lanes 6-14 represent additional
mutants of pIFH108. The amounts of three mutant FtsH proteins carrying
substitutions at position 307 (D307A, D307N, and D307E) seem to be
significantly lower than those of the others. However, this is due to
poor recognition of these mutants by the anti-FtsH serum.2
Note that the anti-FtsH serum used was raised against the synthetic
peptide TNRPDVLDPALLRPGR corresponding to residues 300-315 of the SRH
of FtsH (7).
|
|
Because highly conserved residues such as Asp307,
Arg312, and Arg315 were found to be important
for FtsH function by alanine scanning mutagenesis, we constructed
further mutants that introduce less drastic substitutions at these
positions. Specifically, we changed Asp307 (negatively charged) to Asn
(polar but uncharged) or Glu (similarly negatively charged) or
Arg312 and Arg315 (positively charged) to Leu
(bulky and uncharged) or Lys (similarly positively charged). The
mutants D307N, R312L, R312K, R315L, and R315K showed no detectable
protease activity (Fig. 2B, lanes 7-12). The
mutant D307E exhibited a low but nevertheless significant protease
activity similar to T300A and L310A. Thus, the negative charge of the
Asp307 side chain seems to be important for FtsH activity.
On the other hand, the two conserved Arg residues, Arg312
and Arg315, could not be functionally substituted by Lys
even though the positive charge is retained with this substitution.
For comparison, we constructed additional mutants that have mutations
outside the SRH. The K201N substitution resides in the Walker A motif,
which is believed to be essential for ATPase activity, whereas the
E418Q and H421Y mutations are in the Zn2+-binding motif
believed to form the active site of the protease domain. As expected,
the mutants E418Q and H421Y had no protease activity (Fig.
2B, lanes 13 and 14). The mutant K201N
also showed no detectable protease activity (Fig. 2B,
lane 6), confirming the notion that the protease activity is
dependent on the ATPase activity.
Complementation of the Temperature-sensitive ftsH1
Mutation--
To determine whether or not SRH mutants retain the
essential functions of FtsH for cell growth, the ability of the mutants to complement the temperature-sensitive ftsH1 mutation was
examined. Wild type and mutant pIFH108 plasmids were introduced into
the ftsH1 strain AR754, and the growth of the transformants
was examined at 42 °C in the presence of IPTG (Fig.
3). Under these conditions, wild type and
mutant plasmid encoded FtsH proteins are expressed at levels comparable
with that from the chromosomal ftsH gene (data not shown).
Wild type FtsH and the mutants T300A and D307E, which exhibit a low
in vivo protease activity, complemented ftsH1, whereas the other SRH mutants lacking the protease activity did not.
Because the mutants K201N and H421Y also failed to complement ftsH1, it is clear that the ability of FtsH to complement
ftsH1 is related to the in vivo protease
activity.

View larger version (36K):
[in this window]
[in a new window]
|
Fig. 3.
Complementation of ftsH1(Ts)
by wild type and mutant FtsH proteins. AR754 is a
temperature-sensitive mutant of ftsH (24). vector
and wild-type represent AR754 harboring pIFH100 and pIFH108,
respectively. K201N, T300A, D307N, D307E, R312L, R312K, R315L, R315K,
and H421Y indicate AR754 harboring pIFH108 carrying the specified
mutations. Cells were incubated on L agar plates with 1 mM
IPTG at 42 °C.
|
|
In Vitro Protease Activity--
To examine the activities of these
mutants in vitro, we purified wild type FtsH and the mutants
K201N, T300A, D307N, D307E, R312L, R315L, and H421Y to near
homogeneity. All of the mutant proteins purified in this study behaved
as high molecular mass complexes upon Superose 6 size fractionation
(see "Experimental Procedures") similar to the wild type protein
(data not shown), indicating that their oligomeric states are not
significantly affected by the mutations. Using these purified FtsH
proteins, we tested the in vitro protease activity toward
the
32 substrate (Fig. 4).
ATP-dependent degradation of C-terminally histidine-tagged
32 was observed only with wild type FtsH. Significant
proteolysis was not observed with any of the mutant FtsH proteins. The
low proteolytic activities of the mutants T300A and D307E observed in vivo were not detected in the less sensitive in
vitro assay used. Overall, these in vitro results seem
to be consistent with in vivo results described above.

View larger version (50K):
[in this window]
[in a new window]
|
Fig. 4.
In vitro protease activity of wild
type and mutant FtsH proteins. 3 µg of purified C-terminally
histidine-tagged 32 was degraded by wild type and mutant
FtsH proteins (1 µg each) in vitro under the standard
conditions for 40 min at 42 °C. The reaction products were analyzed
by 10% SDS-PAGE followed by Coomassie Brilliant Blue staining.
|
|
In Vitro NTPase Activity--
We measured the NTPase activities of
the purified wild type and mutant FtsH proteins (Table
I). Among the four nucleotides, FtsH
hydrolyzed ATP and CTP efficiently. This is consistent with the
observation that CTP, but not GTP or UTP, can substitute for ATP in the
degradation of
32 and SecY (8, 16). Interestingly,
however, FtsH also hydrolyzed GTP and UTP at appreciable rates. The
reason that GTP and UTP do not support the proteolysis reaction is
unknown.
The specific activity of wild type FtsH in ATP hydrolysis is ~459
nmol/min/mg. As expected, the mutant K201N showed no detectable ATPase
activity. This also excludes the possibility of significant contamination of any other ATPases in FtsH preparations purified by the
procedures used. Among the SRH mutants, T300A and D307E, which both
have low protease activity, have low specific ATPase activities of
~70 and ~40 nmol/min/mg, respectively. The other SRH mutants D307N,
R312L, and R315L, which have lost the protease activity completely,
showed no detectable ATPase activity. Thus, it seems that the SRH is
important for both the ATPase and the protease activity of FtsH,
presumably because these two activities are tightly coupled.
Interestingly, the ATPase activity of the mutant H421Y decreased to
about a quarter of that of wild type FtsH (~107 nmol/min/mg), even
though this mutation is in the Zn2+-binding motif essential
for the protease activity. The H421Y mutant did not rescue the
lethality of the ftsH1 mutation at the nonpermissive
temperature (Fig. 3), indicating that the protease activity of FtsH is
essential for cell growth regardless of its ATPase activity.
ATP-induced Conformational Change--
As some SRH mutants showed
defects in nucleotide hydrolysis, it is important to establish whether
or not they are defective in nucleotide binding. We have tried
unsuccessfully to demonstrate ATP binding by FtsH in gel filtration
assays, ATP agarose chromatography assays, and UV cross-linking assays
employing radiolabeled ATP.2
We therefore followed the procedures developed by Akiyama et al. (23), which allowed us to detect conformational changes in
FtsH induced by ATP binding.
As shown in Fig. 5A, wild type
FtsH undergoes a conformational change in the presence of ATP, which is
characterized by partial protection of an ~33-kDa ATPase domain from
trypsin digestion. This conformational change is not detected for the
Walker motif mutant K201N, which does not bind ATP (Fig.
5B). We examined three representative SRH mutants, D307N,
R312L, and R315L, which showed no detectable ATPase activity as
described above, for the ATP-induced conformational change. As shown in
Fig. 5 (C-E), the ~33-kDa fragment of all three mutants
was protected from proteolytic degradation by the presence of ATP to a
similar extent to that seen for wild type FtsH. Thus, it is most likely
that mutations in the SRH do not significantly affect the ability of
FtsH to bind ATP, indicating that the SRH plays a catalytic rather than
simply a binding role in ATP hydrolysis. There is no obvious difference
in the pattern of fragments generated by trypsin digestion of wild type
and mutant FtsH proteins, suggesting that the amino acid alterations in
these mutants do not significantly affect the overall structure of
FtsH.

View larger version (30K):
[in this window]
[in a new window]
|
Fig. 5.
ATP-induced conformational change of
FtsH. Wild type and mutant FtsH proteins (10 µg each) were
incubated with trypsin (2.5 µg/ml) in the presence (+) or absence
( ) of 4 mM ATP on ice. Samples were removed at 0, 0.5, 1, 2, 4, and 8 min after the addition of trypsin (left to
right) and analyzed by 10% SDS-PAGE followed by Western
blotting with the anti-FtsH serum.
|
|
 |
DISCUSSION |
In this paper, we have investigated the function of the SRH in
FtsH. The results indicate that the highly conserved residues in the
SRH are important for its ATPase activity. Among the pool of SRH
mutants examined, there is clear correlation between the ATPase and
protease activities. It is most likely that mutations in the SRH affect
the ATPase activity directly with the effects on the protease activity
of FtsH being an indirect consequence of the tight coupling of the two
activities. The consequences of mutations in the SRH match those seen
for Walker motif mutations such as K201N.
Crystal Structure of the AAA Module--
Recently, the crystal
structure of the hexamerization domain of
N-ethylmaleimide-sensitive fusion protein (NSF-D2) in
complex with ATP or its analog AMPPNP has been solved, providing the
first high resolution structural data on an AAA module (31, 32).
NSF contains two AAA modules, D1 and D2, that are different in function
and sequence. D1, whose sequence closely matches the consensus sequence
for the AAA module, catalyzes ATP hydrolysis (33), whereas D2, whose
sequence is only moderately homologous to the consensus sequence of the
AAA module, binds ATP and mediates hexamerization of NSF but displays
no significant ATPase activity (33-36). Thus, although the structure
of D2 reveals the general fold of the AAA module and the determinants
of nucleotide binding and hexamerization, the precise mechanism of ATP
hydrolysis and ATP-induced conformational change have yet to be
elucidated. To interpret the data from the site-directed mutagenesis
experiments on the SRH of FtsH, we have aligned the sequence of the AAA
module of FtsH with those of other AAA modules including D2 and
examined these alignments in the context of the crystal structure of
NSF-D2 (Fig. 6).

View larger version (56K):
[in this window]
[in a new window]
|
Fig. 6.
Modeling of the AAA module. A
and B, orthogonal views of the main chain topology and the
bound AMPPNP ligand in the crystal structure of the NSF-D2 domain. One
molecule of the hexamer is shown. The adenine nucleotide
(ball-and-stick) sits in the cavity between a classical
/ nucleotide-binding domain and a distal helical domain. The mode
of binding of the triphosphate species of the ligand is similar to that
in other proteins that contain the Walker motifs A (blue)
and B (green). The A motif gives rise to the P-loop, which
forms a series of contacts to the and phosphate groups. The
sequence making up the SRH motif is red. C,
contacts made by the SRH of NSF-D2 with AMPPNP. AMPPNP is bound to the
protomer whose SRH (SRH-1) is red. A second SRH (SRH-2),
which is blue, is that of a neighboring protomer. Sw
I represents switch I. Wat and Mg2+
represent a water molecule and a Mg2+ ion bound to the and phosphates of AMPPNP, respectively. D, modeling of
the contacts of the SRH of FtsH with AMPPNP. Ser655,
Ala668, and Ser670 of NSF-D2 were replaced by
the corresponding Asn301, Arg315, and
Asp317 of FtsH, respectively (see the sequence alignment
shown in E). Arg finger? represents a putative
arginine finger of the SRH (SRH-2) of the neighboring protomer (for
detail see "Discussion"). The replacements were made using simple
modeling procedures implemented in the molecular graphics program
QUANTA. Panels A-D were produced using the program
MOLSCRIPT (56). E, sequence alignment of the AAA module.
Sequences of the AAA module of several AAA proteins were aligned using
the program CLUSTAL W (57). NSF-D2 and NSF-D1 represent the D2 and D1
domains of Chinese hamster ovary NSF (58). FtsH represents E. coli FtsH (6, 27). Cdc48p, Sug1p, and Vps4p represent
Saccharomyces cerevisiae Cdc48p (59), Sug1p (4), and Vps4p
(60), respectively. The secondary structure is assigned on the basis of
the NSF-D2 crystal structure (31, 32).
|
|
Functions of the SRH in ATP Hydrolysis--
The SRH corresponds to
the segment connecting strands
4 and
5 of the
-sheet in the
N-terminal nucleotide-binding domain of NSF-D2 (Fig. 6, A,
B, and E). There is a conserved Asn or Ser residue just downstream of strand
4, and the Ser residue in the D2
crystal structure interacts with a water molecule that itself interacts
with the
-phosphate of ATP (Fig. 6C and Refs. 31 and 32).
This conserved Asn/Ser may be involved in hydrolysis of ATP in FtsH and
other AAA domains that possess ATPase activity. The observation that
the Asn residue at this position in FtsH, Asn301, is
important for the protease activity (Fig. 2A) is consistent with this hypothesis. However, the rest of the SRH is remote from the
ATP-binding pocket and the main body of the SRH cannot interact with
ATP directly (Fig. 6, A and B). Our results
indicate that the highly conserved residues in this region,
Asp307, Arg312, and Arg315, are
important for the ATPase activity but not for ATP binding (Table I and
Fig. 5).
NSF forms a hexamer (31, 32, 37). FtsH also forms a ring-like
homo-oligomer similar to the NSF hexamer (12). Indeed, such structures
may be a general feature of AAA proteins, because several other AAA
proteins also form similar hexameric rings (38-43). The 26 S
proteasome contains six distinct but homologous AAA ATPases, and they
are included in the base of the regulatory particle of the proteasome
(44). Thus, it is reasonable to assume that they form a
hetero-hexameric ring similar to the homo-hexamer of NSF-D2.
The SRH of NSF-D2 forms a part of the interface between neighboring
protomers in the hexamer (31, 32). It seems likely therefore that the
SRH will be important for protomer-protomer interaction in FtsH. This
type of intersubunit interaction may be required for its ATPase
activity and indeed accumulating evidence suggests that the ATPase
activity of several AAA proteins including NSF (34, 35), p97 (39), and
Vps4p (45), is greatly enhanced by oligomer formation. The N-terminal
transmembrane and periplasmic domains of FtsH are important for its
stable oligomerization (46, 47). The deletion of the periplasmic domain
lowers the ATPase activity of FtsH 5-fold (47). We have also observed
very low or almost no ATPase activity with truncated forms of FtsH
corresponding to the ATPase domain. Because these fragments behave as
monomers,3 it is likely that
the function of the SRH in ATP hydrolysis is dependent on the
oligomeric state of FtsH.
The sequence conservation in the SRH of D2 is low as shown in Fig.
6E. The SRH sequence of D2 is
653TTSRKDVLQEMEMLNAFS670, whereas the consensus
SRH sequence in the AAA family proteins is
X(T/S)(N/S)XXXXXDXAXXRXXRX(D/E)
(see also Fig. 1B). Only the first two of the highly
conserved "signature" residues are conserved in D2. The alignments
presented in Fig. 6E suggest that Arg315 of FtsH
corresponds to Ala668 of NSF-D2. In a simple modeling
experiment, this alanine residue was replaced with an arginine residue.
The possible conformations of the arginine side chain were then
explored to investigate whether Arg315 could interact with
the ATP ligand and account for its key role in the ATPase activity.
Firstly the preferred arginine side chain rotamers were explored. A
promising conformation was chosen and small manual adjustments to the
side chain torsion angles subsequently brought the guanidino moiety of
the arginine into close proximity to the
-phosphate group of the
AMPPNP ligand that is bound by the neighboring subunit in the hexamer
(Fig. 6D). This suggests the possibility of an intersubunit
catalytic function. This situation would be reminiscent of the
interactions of the so-called "arginine fingers" of
GTPase-activating proteins with their respective small GTP-binding
proteins Ras and Rho. The arginine finger greatly enhances GTP
hydrolysis by stabilizing developing charge formed in the transition
state of the reaction (for a review see Ref. 48). The effects of the
R315L mutation reported here indicate that Arg315 could
fulfill this role in FtsH. The possibility that the Arg residue
corresponding to Arg315 interacts with the
-phosphate
group of ATP bound to the neighboring subunit has independently been
proposed for the AAA and related ATPases, collectively designated the
AAA+ family, simply from multiple sequence alignment and
structural analysis (49, 50). Our present data have provided the first experimental evidence to support these consistent models and have shown
that the Arg residue is involved in ATP hydrolysis.
There are some monomeric AAA proteins that exhibit low but significant
ATPase activity. This is not necessarily inconsistent with the
hypothesis discussed above, because these proteins may form oligomers
only transiently under the ATPase assay conditions. Vps4p undergoes
concentration-dependent oligomerization, which is
accompanied by a dramatic increase in ATPase activity (45).
The model depicted in Fig. 6D does not explain the roles of
the other highly conserved residues such as Asp307 and
Arg312 in the SRH of FtsH. Further work is needed to
account for their strong conservation and their crucial role in the
ATPase activity.
There has been only one report concerning SRH mutations to date.
Shirahama et al. (51) isolated yeast mutants that induce autophagy even in the presence of nutrients and found that one class of
mutants has a mutation in the vps4/csc1 gene. The
mutation was identified as E291K, which corresponds to
Asp317 of FtsH (Fig. 6E). Complete loss of the
vps4/csc1 gene does not induce autophagy in rich
media, and an additional mutation (K179A) in Walker motif A also
abolished the mutant phenotype. These results suggest a
gain-of-function allele in the mutant. The mutant protein might be
defective in ATP hydrolysis but not in ATP binding in a similar manner
to the SRH mutants of FtsH.
Additional Functions of the SRH--
In small G proteins such as
Ras and Rho and motor proteins such as myosins and kinesins, there are
regions referred to as "switches" (for a review see Ref. 52). These
regions undergo dramatic conformational changes upon GTP or ATP
hydrolysis and have been postulated to transmit signals through
interactions with other proteins. The position of one of these switches
(switch I) corresponds to the SRH of the AAA module (Fig. 6,
C and D). The ATPase activity of several
helicases has been demonstrated to be greatly enhanced by DNA or RNA
binding. In the case of DEXX box helicases, motif III, whose
position in the crystal structure also corresponds to the SRH of the
AAA module, has been implicated as one of the sites for DNA binding
(53). In this respect, it should be noted that a proteasomal AAA
ATPase, Sug1p, has been shown to have a 3'-5' DNA helicase activity
(54). It has also been demonstrated that its ATPase activity is
stimulated by specific RNAs (55). We speculate that the SRH of the AAA
module functions similarly as a switch (Fig. 6, C and
D). In FtsH, the SRH might interact with the protease
domain. The low observed ATPase activity of the mutant H421Y (Table I)
might be due to an alteration in the interaction between the AAA module
and the protease domain mediated through the SRH. This interaction may
be crucial in the coupling of the ATPase and protease activities. The
SRH of Vps4p/Csc1p might interact with a molecule essential for
autophagy, and the gain-of-function mutation E291K might affect this
interaction. To elucidate the mechanism of ATP hydrolysis in AAA
proteins and in particular to determine the role of the SRH in this
function, it will be necessary to extend crystallographic
investigations and determine the structures of ATP- and ADP-bound forms
of an enzymatically active representative of the family.
 |
ACKNOWLEDGEMENTS |
We thank Y. Akiyama for plasmids and helpful
discussions, H. Matsuzawa for the plasmid pQM21, and A. Lupas for
stimulating discussions. We are also grateful to S. Hiraga, H. Niki,
and M. Yamazoe for generous support of this work and to C. Ichinose, E. Ikeda, and Y. Kawata for technical and secretarial assistance.
 |
FOOTNOTES |
*
This work was supported in part by grants from the Ministry
of Education, Science, Sports and Culture of Japan (to T. O.) and
a grant from the Wellcome Trust (to A. J. W.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
The atomic coordinates and the structure factors (code 1D2N) have been deposited in the Protein Data Bank, Research Collaboratory for Structural Bioinformatics, Rutgers University, New Brunswick, NJ (http://www.rcsb.org/).
¶
To whom correspondence should be addressed. Tel.:
81-96-373-5335; Fax: 81-96-371-2408; E-mail:
ogura@gpo.kumamoto-u.ac.jp.
2
K. Karata, and T. Ogura, unpublished results.
3
T. Inagawa, K. Karata, and T. Ogura, unpublished results.
 |
ABBREVIATIONS |
The abbreviations used are:
SRH, second region
of homology;
PhoA, alkaline phosphatase;
PAGE, polyacrylamide gel
electrophoresis;
IPTG, isopropyl-1-thio-
-D-galactopyranoside;
AMPPNP, 5'-adenylyl-
,
-imidodiphosphate.
 |
REFERENCES |
| 1.
|
Confalonieri, F.,
and Duguet, M.
(1995)
Bioessays
17,
639-665[CrossRef][Medline]
[Order article via Infotrieve]
|
| 2.
|
Beyer, A.
(1997)
Protein Sci.
6,
2043-2058[Abstract]
|
| 3.
|
Patel, S.,
and Latterich, M.
(1998)
Trends Cell Biol.
8,
65-71[Medline]
[Order article via Infotrieve]
|
| 4.
|
Swaffield, J. C.,
Bromberg, J. F.,
and Johnston, S. A.
(1992)
Nature
357,
698-700[CrossRef][Medline]
[Order article via Infotrieve]
|
| 5.
|
Ogura, T.,
Tomoyasu, T.,
Yuki, T.,
Morimura, S.,
Begg, K. J.,
Donachie, W. D.,
Mori, H.,
Niki, H.,
and Hiraga, S.
(1991)
Res. Microbiol.
142,
279-282[Medline]
[Order article via Infotrieve]
|
| 6.
|
Tomoyasu, T.,
Yuki, T.,
Morimura, S.,
Mori, H.,
Yamanaka, K.,
Niki, H.,
Hiraga, S.,
and Ogura, T.
(1993)
J. Bacteriol.
175,
1344-1351[Abstract/Free Full Text]
|
| 7.
|
Tomoyasu, T.,
Yamanaka, K.,
Murata, K.,
Suzaki, T.,
Bouloc, P.,
Kato, A.,
Niki, H.,
Hiraga, S.,
and Ogura, T.
(1993)
J. Bacteriol.
175,
1352-1357[Abstract/Free Full Text]
|
| 8.
|
Tomoyasu, T.,
Gamer, J.,
Bukau, B.,
Kanemori, M.,
Mori, H.,
Rutman, A. J.,
Oppenheim, A. B.,
Yura, T.,
Yamanaka, K.,
Niki, H.,
Hiraga, S.,
and Ogura, T.
(1995)
EMBO J.
14,
2551-2560[Medline]
[Order article via Infotrieve]
|
| 9.
|
Herman, C.,
Thévenet, D.,
D'Ari, R.,
and Bouloc, P.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
3516-3520[Abstract/Free Full Text]
|
| 10.
|
Ogura, T.,
Inoue, K.,
Tatsuta, T.,
Suzaki, T.,
Karata, K.,
Young, K.,
Su, L.-H.,
Fierke, C. A.,
Jackman, J. E.,
Raetz, C. R. H.,
Coleman, J.,
Tomoyasu, T.,
and Matsuzawa, H.
(1999)
Mol. Microbiol.
31,
833-844[CrossRef][Medline]
[Order article via Infotrieve]
|
| 11.
|
Herman, C.,
Thévenet, D.,
Bouloc, P.,
Walker, G. C.,
and D'Ari, R.
(1998)
Genes Dev.
12,
1348-1355[Abstract/Free Full Text]
|
| 12.
|
Shotland, Y.,
Koby, S.,
Teff, D.,
Mansur, N.,
Oren, D. A.,
Tatematsu, K.,
Tomoyasu, T.,
Kessel, M.,
Bukau, B.,
Ogura, T.,
and Oppenheim, A. B.
(1997)
Mol. Microbiol.
24,
1303-1310[CrossRef][Medline]
[Order article via Infotrieve]
|
| 13.
|
Herman, C.,
Thévenet, D.,
D'Ari, R.,
and Bouloc, P.
(1997)
J. Bacteriol.
179,
358-363[Abstract/Free Full Text]
|
| 14.
|
Leffers, G. G.,
and Gottesman, S.
(1998)
J. Bacteriol.
180,
1573-1577[Abstract/Free Full Text]
|
| 15.
|
Kihara, A.,
Akiyama, Y.,
and Ito, K.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
4532-4536[Abstract/Free Full Text]
|
| 16.
|
Akiyama, Y.,
Kihara, A.,
Tokuda, H.,
and Ito, K.
(1996)
J. Biol. Chem.
271,
31196-31201[Abstract/Free Full Text]
|
| 17.
|
Akiyama, Y.,
Kihara, A.,
and Ito, K.
(1996)
FEBS Lett.
399,
26-28[CrossRef][Medline]
[Order article via Infotrieve]
|
| 18.
|
Kihara, A.,
Akiyama, Y.,
and Ito, K.
(1998)
J. Mol. Biol.
279,
175-188[CrossRef][Medline]
[Order article via Infotrieve]
|
| 19.
|
Akiyama, Y.,
Ogura, T.,
and Ito, K.
(1994)
J. Biol. Chem.
269,
5218-5224[Abstract/Free Full Text]
|
| 20.
|
Tatsuta, T.,
Tomoyasu, T.,
Bukau, B.,
Kitagawa, M.,
Mori, H.,
Karata, K.,
and Ogura, T.
(1998)
Mol. Microbiol.
30,
583-594[CrossRef][Medline]
[Order article via Infotrieve]
|
| 21.
|
Akiyama, Y.,
Shirai, Y.,
and Ito, K.
(1994)
J. Biol. Chem.
269,
5225-5229[Abstract/Free Full Text]
|
| 22.
|
Shirai, Y.,
Akiyama, Y.,
and Ito, K.
(1996)
J. Bacteriol.
178,
1141-1145[Abstract/Free Full Text]
|
| 23.
|
Akiyama, Y.,
Ehrmann, M.,
Kihara, A.,
and Ito, K.
(1998)
Mol. Microbiol.
28,
803-812[CrossRef][Medline]
[Order article via Infotrieve]
|
| 24.
|
Begg, K. J.,
Tomoyasu, T.,
Donachie, W. D.,
Khattar, M.,
Niki, H.,
Yamanaka, K.,
Hiraga, S.,
and Ogura, T.
(1992)
J. Bacteriol.
174,
2416-2417[Abstract/Free Full Text]
|
| 25.
|
Studier, F. W.,
and Moffatt, B. A.
(1986)
J. Mol. Biol.
189,
113-130[CrossRef][Medline]
[Order article via Infotrieve]
|
| 26.
|
Qu, J. N.,
Makino, S.,
Adachi, H.,
Koyama, Y.,
Akiyama, Y.,
Ito, K.,
Tomoyasu, T.,
Ogura, T.,
and Matsuzawa, H.
(1996)
J. Bacteriol.
178,
3457-3461[Abstract]
|
| 27.
|
Wang, R.-F.,
O'Hara, E. B.,
Aldea, M.,
Bargmann, C. I.,
Gromley, H.,
and Kushner, S. R.
(1998)
J. Bacteriol.
180,
1929-1939[Abstract/Free Full Text]
|
| 28.
|
Ausubel, F. M.,
Brent, R.,
Kingston, R. E.,
Moore, D. D.,
Seidman, J. G.,
Smith, J. A.,
Struhl, K.,
Albright, L. M.,
Coen, D. M.,
and Varki, A.
(1991)
Current Protocols in Molecular Biology
, John Wiley & Sons, Inc., New York
|
| 29.
|
Gamer, J.,
Bujard, H.,
and Bukau, B.
(1992)
Cell
69,
833-842[CrossRef][Medline]
[Order article via Infotrieve]
|
| 30.
|
Cunningham, B. C.,
and Wells, J. A.
(1989)
Science
244,
1081-1085[Abstract/Free Full Text]
|
| 31.
|
Lenzen, C. U.,
Steinmann, D.,
Whiteheart, S. W.,
and Weis, W. I.
(1998)
Cell
94,
525-536[CrossRef][Medline]
[Order article via Infotrieve]
|
| 32.
|
Yu, R. C.,
Hanson, P. I.,
Jahn, R.,
and Brünger, A. T.
(1998)
Nat. Struct. Biol.
5,
803-811[CrossRef][Medline]
[Order article via Infotrieve]
|
| 33.
|
Whiteheart, S. W.,
Rossnagel, K.,
Buhrow, S. A.,
Brunner, M.,
Jaenicke, R.,
and Rothman, J. E.
(1994)
J. Cell Biol.
126,
945-954[Abstract/Free Full Text]
|
| 34.
|
Nagiec, E. E.,
Bernstein, A.,
and Whiteheart, S. W.
(1995)
J. Biol. Chem.
270,
29182-29188[Abstract/Free Full Text]
|
| 35.
|
Matveeva, E. A.,
He, P.,
and Whiteheart, S. W.
(1997)
J. Biol. Chem.
272,
26413-26418[Abstract/Free Full Text]
|
| 36.
|
Fleming, K. G.,
Hohl, T. M., Yu, R. C.,
Müller, S. A.,
Wolpensinger, B.,
Engel, A.,
Engelhardt, H.,
Brünger, A. T.,
Söllner, T. H.,
and Hanson, P. I.
(1998)
J. Biol. Chem.
273,
15675-15681[Abstract/Free Full Text]
|
| 37.
|
Hanson, P. I.,
Roth, R.,
Morisaki, H.,
Jahn, R.,
and Heuser, J. E.
(1997)
Cell
90,
523-535[CrossRef][Medline]
[Order article via Infotrieve]
|
| 38.
|
Peters, J.-M.,
Walsh, M. J.,
and Franke, W. W.
(1990)
EMBO J.
6,
1757-1767[Medline]
[Order article via Infotrieve]
|
| 39.
|
Peters, J.-M.,
Harris, J. R.,
Lustig, A.,
Müller, S.,
Engel, A.,
Volker, S.,
and Franke, W. W.
(1992)
J. Mol. Biol.
223,
557-571[CrossRef][Medline]
[Order article via Infotrieve]
|
| 40.
|
Zang, L.,
Ashendel, C. L.,
Becker, G. W.,
and Morré, D. J.
(1994)
J. Cell Biol.
127,
1871-1883[Abstract/Free Full Text]
|
| 41.
|
Fröhlich, K.-U.,
Fries, H. W.,
Peters, J.-M.,
and Mecke, D.
(1995)
Biochim. Biophys. Acta
1253,
25-32[CrossRef][Medline]
[Order article via Infotrieve]
|
| 42.
|
Pamnani, V.,
Tamura, T.,
Lupas, A.,
Peters, J.,
Cejka, Z.,
Ashraf, W.,
and Baumeister, W.
(1997)
FEBS Lett.
404,
263-268[CrossRef][Medline]
[Order article via Infotrieve]
|
| 43.
|
Wolf, S.,
Nagy, I.,
Lupas, A.,
Pfeifer, G.,
Cejka, Z.,
Müller, S. A.,
Engel, A.,
Mot, R. D.,
and Baumeister, W.
(1998)
J. Mol. Biol.
277,
13-25[CrossRef][Medline]
[Order article via Infotrieve]
|
| 44.
|
Glickman, M. H.,
Rubin, D. M.,
Coux, O.,
Wefes, I.,
Pfeifer, G.,
Cjeka, Z.,
Baumeister, W.,
Fried, V. A.,
and Finley, D.
(1998)
Cell
94,
615-623[CrossRef][Medline]
[Order article via Infotrieve]
|
| 45.
|
Babst, M.,
Wendland, B.,
Estepa, E. J.,
and Emr, S. D.
(1998)
EMBO J.
17,
2982-2993[CrossRef][Medline]
[Order article via Infotrieve]
|
| 46.
|
Akiyama, Y.,
Yoshihisa, T.,
and Ito, K.
(1995)
J. Biol. Chem.
270,
23485-23490[Abstract/Free Full Text]
|
| 47.
|
Akiyama, Y.,
Kihara, A.,
Mori, H.,
Ogura, T.,
and Ito, K.
(1998)
J. Biol. Chem.
273,
22326-22333[Abstract/Free Full Text]
|
| 48.
|
Scheffzek, K.,
Ahmadian, M. R.,
and Wittinghofer, A.
(1998)
Trends Biochem. Sci.
23,
257-262[CrossRef][Medline]
[Order article via Infotrieve]
|
| 49.
|
Neuwald, A. F.,
Aravind, L.,
Spouge, J. L.,
and Koonin, E. V.
(1999)
Genome Res.
9,
25-41
|
| 50.
|
Neuwald, A. F.
(1999)
Structure
7,
R19-R23[Medline]
[Order article via Infotrieve]
|
| 51.
|
Shirahama, K.,
Noda, T.,
and Ohsumi, Y.
(1997)
Cell Struct. Funct.
22,
501-509[Medline]
[Order article via Infotrieve]
|
| 52.
|
Vale, R. D.
(1996)
J. Cell Biol.
135,
291-302[Free Full Text]
|
| 53.
|
Korolev, S.,
Hsieh, J.,
Gauss, G. H.,
Lohman, T. M.,
and Waksman, G.
(1997)
Cell
90,
635-647[CrossRef][Medline]
[Order article via Infotrieve]
|
| 54.
|
Fraser, R. A.,
Rossignol, M.,
Heard, D. J.,
Egly, J. M.,
and Chambon, P.
(1997)
J. Biol. Chem.
272,
7122-7126[Abstract/Free Full Text]
|
| 55.
|
Makino, Y.,
Yamano, K.,
Kanemaki, M.,
Morikawa, K.,
Kishimoto, T.,
Shimbara, N.,
Tanaka, K.,
and Tamura, T.
(1997)
J. Biol. Chem.
272,
23201-23205[Abstract/Free Full Text]
|
| 56.
|
Kraulis, P. J.
(1991)
J. Appl. Crystallogr.
24,
946-950[CrossRef]
|
| 57.
|
Thompson, J. D.,
Higgins, D. G.,
and Gibson, T. J.
(1994)
Nucleic Acids Res.
22,
4673-4680[Abstract/Free Full Text]
|
| 58.
|
Wilson, D. E.,
Wilcox, C. A.,
Flynn, G. C.,
Chen, E.,
Kuang, W.-J.,
Henzel, W. J.,
Block, M. R.,
Ullrich, A.,
and Rothman, J. E.
(1989)
Nature
339,
355-359[CrossRef][Medline]
[Order article via Infotrieve]
|
| 59.
|
Fröhlich, K.-U.,
Fries, H. W.,
Rüdiger, M.,
Erdmann, R.,
Botstein, D.,
and Mecke, D.
(1991)
J. Cell Biol.
114,
443-453[Abstract/Free Full Text]
|
| 60.
|
Bussey, H.,
et al..
(1997)
Nature
387 (suppl.),
103-105[Medline]
[Order article via Infotrieve]
|
Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. J. Page and E. Di Cera
Evolution of Peptidase Diversity
J. Biol. Chem.,
October 31, 2008;
283(44):
30010 - 30014.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Nishikori, K. Yamanaka, T. Sakurai, M. Esaki, and T. Ogura
p97 homologs from Caenorhabditis elegans, CDC-48.1 and CDC-48.2, suppress the aggregate formation of huntingtin exon1 containing expanded polyQ repeat.
Genes Cells,
August 1, 2008;
13(8):
827 - 838.
[Abstract]
[Full Text]
[PDF]
|
 |
|